Open Access

Increased activation and cytokine secretion in B cells stimulated with leptin in aged humans

Immunity & Ageing201310:3

DOI: 10.1186/1742-4933-10-3

Received: 30 November 2012

Accepted: 13 January 2013

Published: 23 January 2013

Abstract

Aging is associated chronic inflammation and autoimmunity, and increased levels of leptin. Increased levels of leptin are associated with inflammation and autoimmunity. We have recently reported that leptin activates B cells to induce secretion of proinflammatory and anti-inflammatory cytokines. Role of B cells and leptin in inflammation associated with aging has not been explored. In this study we demonstrate that leptin activates and induces significantly greater amount of IL-6, TNF-α, and IL-10 by B cells from aged humans as compared to young controls. This is associated with increased leptin-induced phosphorylation of STAT3 (signal transducer and activator of transcription-3) in B cells from aged humans as compared to young subjects. These data suggest that leptin-induced B cell-derived proinflammatory cytokines may play a role in chronic inflammation associated with human aging.

Keywords

TNF-α IL-6 IL-10 B cells

Background

Leptin, one of adipokines induces secretion of a number of proinflammatory cytokines, including IL-6, IL-1, and TNF-α [15]. Serum levels of leptin,TNF-α, IL-6, and other proinflammatory cytokines are increased during human aging and age-associated inflammatory disorders [615]. However, the cellular source of these cytokines in aging is poorly understood. These cytokines are produced by T cells, macrophages, and B cells. However, T cell-derived and macrophage-derived proinflammatory cytokines are decreased in aging [1620]. Therefore, B cells are likely the source of increased proinflammatory cytokines in aging. B cell derived inflammatory cytokines have not been studied in aging. During aging adipose tissue is increased in the lymph nodes and the bone marrow, which may result in leptin levels that may be 10 to 100 fold greater than those in plasma. In addition to their well-defined role in antibody production, B cells may also regulate immune responses to microbes and participate in inflammation through production of cytokines, chemokines, and growth factors [2124]. Human B cells have shown to produce cytokines, including proinflammatory cytokines IL-6, TNF-α, and immunoregulatory and anti-inflammatory cytokines, such TGF-β, and IL-10 [2124]. We have recently reported that leptin activates human B cells to induce secretion of IL-6 and TNF-α and IL-10, and this effect of leptin on B cells is mediated via JAK2/STAT3 and p38MAPK/ERK1/2 signaling pathways [25].

In this study, we show that leptin activates B cells and B cell subsets from aged subjects to a significantly greater extent, and induces significantly higher levels of secretion of IL-6, TNF-α, and IL-10 as compared to B cells and B cell subsets from young subjects. This appears to be due to an increased leptin-induced phosphorylation of STAT-3 in B cells from aged as compared to young controls.

Results

Leptin induces greater activation of B cells from aged as compared to young humans

Purified B cells were activated with 50 ng/ml of leptin (optimum concentration-reference# 25) for 24 hours. Cells were washed and stained with anti-CD19 antibody, anti-CD5 antibody, and antibodies directed against CD25, and CD69 as activation markers. Figure 1 shows a representative cytofluorograph. In aging, leptin induced (red line) greater activation (increased expression of CD25 and CD69) over the baseline levels (blue control) as compared to young control. Furthermore, increased activation in aging was observed in both CD5+ and CD5- B cells. Tables 1 and 2 show data from 10 aged and 10 young subjects. A significantly greater upregulation of both CD25 and CD69 antigens over the baseline levels was observed on CD19+, and CD5+ and CD5- B cells in aged humans as compared to B cells and B cell subsets in young (Table 1). Furthermore, greater upregulation was observed in CD5+ B cells as compared to CD5- B cells. When data were analyzed for the density of these molecules as measured by mean fluorescence intensity (MFI), significant increase in aging was observed for CD25 expression (Table 2).
https://static-content.springer.com/image/art%3A10.1186%2F1742-4933-10-3/MediaObjects/12979_2012_Article_125_Fig1_HTML.jpg
Figure 1

Effect of leptin on activation of B cells and B cell subsets. Purified B cells from young and aged subjects were stimulated with leptin (50 ng/ml) for 24 hours and expression of CD25 and CD69 as activation markers, using specific antibodies and isotype controls. Blue lines are for unactivated B cells, and red line for leptin-activated B cells.

Table 1

Effect of Leptin on the expression of activation markers on B cell subsets (%)

Marker

Young

Aged

 

CD19

CD5+

CD5-

CD19

CD5+

CD5-

CD25

Control

2.8 ± 0.4

3.5 ± 0.4

3.0 ± 0.3

3.5 ± 0.2

5.0 ± 0.7

1.8 ± 0.4

Activated

8.3 ± 1.1

4.0 ± −.3

10.0 ± 1.3

26.3 ± 2.8

15.0 ± 2.3

12.0 ± 1.9

CD69

Control

1.8 ± 0.2

2.4 ± 0.5

1.9 ± 0.5

5.5 ± 1.0

3.1 ± 0.4

2.5 ± 0.3

Activated

4.3 ± 0.6

2.6 ± 0.3

4.8 ± 0.3

8.2 ± 0.5

7.6 ± 0.8

6.9 ± 0.4

P value:

CD25, Aging vs. Young: CD19 = P < 0.01, CD5 + = P < 0.001, CD5- = P < 0.05.

CD69, Aging vs. Young: CD19 = P < 0.05, CD5+ = P < 0.01, CD5- = P < 0.05.

Table 2

Effect of Leptin on the expression of activation markers on B cell subsets (MFI)

Marker

Young

Aged

  

CD19

CD5+

CD5-

CD19

CD5+

CD5-

CD25

Control

3.6 ± .4

5.6 ± 2

5.6 ± 2

10 ± 4

7 ± 1.25

10 ± 7

Activated

9.6 ± 1.7

9.5 ± 1.4

9.5 ± 1.4

26 ± 2

15 ± 2.5

51 ± 4.6

CD69

Control

4.5 ± 2

8.8 ± 5

4.1 ± 1.6

4.5 ± .4

7 ± 3.5

3.6 ± 8

Activated

7.6 ± 2.6

11 ± 5.9

7.3 ± 1.7

8.6 ± .47

20 ± 5.7

8 ± .8

P value:

CD25, Aging vs. Young: CD19 = P < 0.01, CD5 + = P < 0.001, CD5- = P < 0.045.

CD69, Aging vs. Young: CD19 = ns, CD5+ = P < 0.02, CD5- = ns.

Leptin-induced production of IL-6, TNF-α, and IL-10 by B cells from young and aged subjects

Purified B cells were stimulated with 25 ng/ml and 50 ng/ml of leptin for 24 hours and supernatants were collected and stored at −20°C until assayed for IL-6, TNF-α, and IL-10 by ELISA. Cytokine secreting B cells were also analyzed by ELISPOT. Figure 2 show data from ELISA assay. Leptin at both 25 ng/ml and 50 ng/ml induced significantly (P < 0.05) greater amounts of IL-6, TNF-α, and IL-10 by B cells from aged as compared to young subjects. Similar data were obtained for IL-6, TNF-α, and IL-10 secreting B cells as determined by ELISPOT assay (Figure 3). We observed no difference in these cytokines production between B cells purified by positive selection versus those purified by negative selection, therefore, excluding any possibility of activation of B cells during positive selection (data not shown).
https://static-content.springer.com/image/art%3A10.1186%2F1742-4933-10-3/MediaObjects/12979_2012_Article_125_Fig2_HTML.jpg
Figure 2

Leptin-induced secretion of cytokines. Purified B cells from young and aged were cultured in the absence or presence of leptin (25 ng/ml and 50 ng/ml) for 24 hours and supernatants were analyzed for TNF-α, IL-6, and IL-10 using ELISA assay. Data are expressed as mean ± sd. Each experiment was done in triplicates.

https://static-content.springer.com/image/art%3A10.1186%2F1742-4933-10-3/MediaObjects/12979_2012_Article_125_Fig3_HTML.jpg
Figure 3

Leptin-stimulated cytokine secreting B cells. Purified B cells (12,500-50,000/well) from young and aged were cultured in the absence or presence of leptin (25 ng/ml and 50 ng/ml) for 24 hours and TNF-α, IL-6, and IL-10 secreting B cells were analyzed by ELISPOT assay. Data are expressed as mean ± sd. Each experiment was done in triplicates.

Increased sensitivity of B cells to leptin in aging is due to increased positive downstream signaling event

Since leptin induces cytokines by activation of downstream signaling pathways, including phosphorylation of STAT3 [25], we examined leptin-induced phosphorylation of STAT3 in purified B cells from aged and young subjects. Purified B cells were stimulated with 50 ng/ml of leptin for 10 min, and phosphorylation of STAT3 was determined by Western blotting using specific antibodies. Actin was used as a loading internal control. Quantitative analysis was performed by densitometry. Figure 4 shows that leptin induces greater phosphorylation of STAT3 in aging B cells as compared to B cells from young subjects suggesting an increased activation of positive downstream signaling in aging.
https://static-content.springer.com/image/art%3A10.1186%2F1742-4933-10-3/MediaObjects/12979_2012_Article_125_Fig4_HTML.jpg
Figure 4

Leptin-induced phosphorylation of STAT3 in B cells. Purified B cells from young and aged were cutlured in the presence and absence of 50 ng/ml leptin for 10 min and native and phosphorylated STAT3 were analyzed by Western blot using specific antibodies. Actin was used an an internal loading control. Quantitation of bands was performed by densitometry and shown in table below.

Discussion

In this study we have demonstrated that leptin activates B cells from aged humans and induces significantly higher amounts of TNF-α, IL-6, and IL-10 as compared to B cells from young subjects. This is in part due to an increased phosphorylation of STAT3.

Aging is considered a state of chronic inflammation. Plasma levels of proinflammatory cytokines, including IL-6 and TNF-α are increased in human aging [611]; however, the cellular source of increased proinflammatory cytokines is poorly understood. These cytokines are produced by T cells, macrophages, and B cells. However, macrophage-derived IL-1β, TNF-α and IL-6 and Th1 derived cytokines are decreased in aging [1620]. Therefore, B cells is likely one of the sources of increased proinflammatory cytokines associated with human aging, though dendritic cells in aging may also contribute to increased levels of proinflammatory cytokines [26]. Recently, B cells have shown to produce a number of cytokines, chemokines, and growth factors with proinflammatory properties [2125].

Leptin is one of adipokines, which is powerful inducer of inflammatory cytokines by Th1 T cells and macrophages, including IFN-γ, IL-1β, TNF-α, and IL-6 [15, 27, 28]. More recently, we have reported that leptin also activates human B cells to induce inflammatory cytokines, including IL-6 and TNF-α, and anti-inflammatory/ immunoregulatory cytokine IL-10 [2931]. We have reported that leptin activates human B cells [25], and serum levels of leptin are increased in aging [1720]. Since leptin and proinflammatory cytokines are increased in aging, and T cell-and macrophage-derived proinflammatory cytokines are decreased in aging, we investigated the effects of leptin on purified B cells. In the present study we show that leptin activates human aged B cells to a greater extent than B cells from young subjects as evidenced by upregulation of CD25 and CD69, which was observed on both CD19 + CD5+ B cells and CD19 + CD5-B cells, greater upregulation was observed in CD5+ B cells as compared to CD5- B cells. CD5+ B cells are reported to produce IL-10 with immunoregulatory property [32], which may explain a role of leptin in autoimmunity [1, 33].

Activation of B cells was also associated with increased production of cytokines by B cells. Leptin induced significantly higher (P < 0.05) secretion of IL-6, TNF-α, and IL-10 by B cells (ELISA assay) from aged humans as compared to B cells from young subjects. Furthermore, we demonstrate that leptin not only induced increased amounts of secreted cytokines by aged B cells, but leptin also increased significantly higher number B cells (ELISPOT assay) to secrete these cytokines. Increase in leptin-induced IL-10 in aging may suggest a compensatory mechanism to counterbalance increased IL-6 and TNF-α production. Since B regulatory cells produce IL-10 [34] it is possible that increased IL-10 production might be due to increased Breg in aging. This possibility is under investigation. IL-10 rescues CD5+ cells from apoptosis and augments the proliferation of CD5- B cells [3539]. Since IL-6 and TNF-α are produced by both CD5+ and CD5- B cells, increased leptin-induced B cell-derived IL-10 in aging may be playing a role in aging-associated chronic inflammation by surviving B cells from apoptosis to produce IL-6 and TNF-α. Buffa et al. [40] have reported an expansion of CD19 + CD38-CD24- B cells in aged humans and these cells produce both TNF-α and IL-10.

Leptin signal via three distinct pathways, including JAK-STAT, PI3K, and MAPK pathways [4143]. Following binding of leptin with leptin receptor, JAK2 (Janus kinase 2) is activated by auto-or cross phosphorylation. Activated JAK2 tyrosine phosphorylates intracellular domain of leptin receptor. The phosphorylated receptor provides a docking site for STAT (signal transducer and activator of transcription) factors, particularly STAT3, which is substrate of JAK2. STAT3 itself is a substrate for JAK2 and homo- or hetero-dimerization upon phosphorylation, translocates to the nucleus, and modulates transcription of genes, including cytokine genes. We show that Leptin induced significantly greater phosphorylation of STAT3 in B cells from aged subjects as compared to B cells from young controls, suggesting that leptin-induced increased cytokine production by aged B cells is via increased activation of STAT3.

Conclusions

Leptin activates B cells from aged humans via increased intracellular signaling to secrete IL-6, TNF-α, and IL-10 to a greater extent than B cells in young subjects, which may contribute to chronic inflammation associated with human aging.

Materials and methods

Subjects

Peripheral blood mononuclear cells (MNCs) were isolated from blood of 10 healthy young (18–35 years, mean 23±4) and 10 healthy aged (66–84 years, mean 74±6) subjects by Ficoll–hypaque density gradient. Aged subjects are healthy people of middle and upper middle social status, and are living active independent lives in the city of Laguna Woods, California (senior community). All subjects were required to discontinue all vitamins and antioxidants (if they were taking) for at least one year prior to donation of blood sample. Protocol was approved by Human Subject Committee of the Institution Review Board of the University of California, Irvine. Consent form approved by the Institutional Review Board of the University of California was signed by each subject. Consent form states that publications and/or presentations that result from this study will not include identifiable information about you.

Antibodies and reagents

The following anti-human immunoglobulins were used: CD19 PerCP, CD69 FITC, CD25 APC, and CD5 PE; all from BD Parmingen (San Jose, CA). B cell enrichment kit was purchased from Stem cell Technologies (Vancouver, BC, Canada), and recombinant human leptin from PeproTech (Rocky Hill, New Jersey).

Immunophenotyping

B cells were stained with, APC-conjugated anti-CD25, FITC-conjugated anti-CD69, PE-conjugated anti-CD5 monoclonal antibodies. After staining, cells were washed extensively with phosphate-buffered saline and analyzed by Flow cytometry using FACScalibur (Becton-Dickenson, San Jose, CA) equipped with argon ion laser emitting at 488 nm (for FITC, PE, and PerCP excitation) and a spatially separate diode laser emitting at 631 nm (for APC excitation). Forward and side scatters were used to gate and exclude cellular debris. Ten thousand cells were acquired and analyzed using Flowjo software (Treestar, Ashland, OR). Data were analyzed for both percentages of cells expressing CD25 and CD69 as well as density of molecules as defined by mean fluoresence intensity (MFI).

Purification of B cells

B lymphocytes were purified by immunomagnetic human B cell enrichment kit according to manufacturer’s instructions (STEMCELL Technologies, Vancouver, Canada). In brief, peripheral blood mononuclear cells were suspended at no more than 1 × 108 cells/ml in PBS containing 2% FBS. Negative selection cocktail (100 μl/ml) was added and incubated at room temperature for 15 min. The magnetic nanoparticles were added at 50 μl/ml cells and incubated for 10 min. Cells were placed in a 12 × 75-mm polystyrene tube at a volume of 2.5 ml/tube and placed into the magnet for 5 min. The magnet was inverted, and the supernatant was poured off. The magnetically labeled unwanted cells remain bound inside the original tube. The purity of negatively selected cells was assessed by flow cytometry (>97%) as detected by the presence of CD20.

Measurement of cytokines

Cytokine secretion was measured by ELISA, and ELISPOT assays. Purified B cells were activated by 25 ng/ml and 50 ng/ml of leptin for 24 h. Supernatants were collected and stored at −20°C until assayed for detection of cytokines by ELISA (ELISA kits from BD Pharmingen, San Jose, CA) as per manufacturer’s protocol. Cytokine secreting cells were measured by ELISPOT assay according to manufacturer’s protocol. In brief, PVDF membrane ELISPOT plates (Millipore, Billerica, MA) were coated with 100 μl (conc. 2 μg/ml) of capture antibody per well (BD Pharmingen, San Jose), and were kept overnight at 4°C. Plates were washed 3 times with sterile PBS and 200 μl/well of sterile blocking buffer was added for ≥ 1 hour. Plates were washed 3 times with sterile PBS. Purified B cells (12,500; 25,000; and 50,000/well) were placed in triplicate. Twenty five and 50 ng/ml leptin was added to each well and plates were incubated at 37°C 5% CO2 incubator for 48 hrs. Plates were first washed x3 times with PBS, and then 3 times with PBS-Tween. 100 μl/well of diluted biotinylated detection antibody (BD Pharmingen, San Jose, California) was added at 2 μg/ml and incubate for 2 hr at room temperature. Plates were washed with PBS-Tween, and 100 μl/ well of the Av-HRP conjugate (BD Pharmingen, San Jose, California) added and incubate at room temperature for 1 hours. 200 μl/well of fresh substrate solution was added and spot/color development was monitored. Reaction was stopped by rinsing plate with tap water, and followed by blotting on paper towels. Plates were allowed to air dry overnight. Spots were counted manually with a dissecting microscope, and expressed as spots/50,000 B cells.

Western blotting

Purified B cells were incubated in the presence or absence of 50 ng/ml of leptin for 10 min, and cells were lysed with lysis buffer. Aliquots of cell lysates containing 20 μg of total protein were resolved by SDS–PAGE and transferred onto membranes (Millipore, Bedford, MA) by electroblotting. The membranes were blocked for 1 h at room temperature in TBS-T buffer with 5% nonfat dried milk and incubated with primary antibodies overnight at 4°C. The blots were washed three times for 20 min with TBS-T buffer and then incubated with HRP-conjugated secondary antibodies (1:3,000–1:6,000 dilution) for 1 h at room temperature. After washing three times for 20 min in TBS-T buffer, blots were developed using enhanced chemiluminescence reagents (ECL, Pierce Biotechnology, Inc., Rockford, IL) and exposed to clear-blue X-Ray film. Actin was used as a loading control. Bands were scanned, and volumes were calculated. Quantification was done by a ratio between STAT-3 or pSTAT-3 and actin.

Statistical analysis was performed by paired student t test

Declarations

Acknowledgement

Authors wish to thank Houfen Su for her technical expertise.

Authors’ Affiliations

(1)
Programs in Primary Immunodeficiency and Aging, Division of Basic and Clinical Immunology,, University of California,
(2)
Medical Sciences I, C-240,, University of California,

References

  1. Cava A, Matarese G: The weight of leptin in autoimmunity. Nat Rev Immunol. 2004, 4: 371-379. 10.1038/nri1350.View ArticlePubMed
  2. Loffreda S, Rai R, Yang SQ: Leptin regulates proinflammatory immune responses. FASEB J. 1998, 12: 57-65.PubMed
  3. Santos-Alvarez J, Goberna R, Sanchez-Margalet V: Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol. 1999, 194: 6-11. 10.1006/cimm.1999.1490.View ArticlePubMed
  4. Martin-Romero C, Santos-Alvarez J, Governa R, Sanchez-Margalet V: Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol. 2000, 199: 15-24. 10.1006/cimm.1999.1594.View ArticlePubMed
  5. Matarese G, Moschos S, Mantzoros CS: Leptin in immunology. J Immunol. 2005, 174: 3137-3142.View ArticlePubMed
  6. Krabbe KS, Pedersen M, Bruunsggaard H: Inflammatory mediators in the elderly. Exp Gerontol. 2004, 39: 687-699. 10.1016/j.exger.2004.01.009.View ArticlePubMed
  7. Sarkar D, Fisher PB: Molecular mechanisms of aging-associated inflammation. Cancer Lett. 2006, 236 (1): 13-23. 10.1016/j.canlet.2005.04.009.View ArticlePubMed
  8. Pedersen M, Bruunsgaard H, Weis N, Hendel HW, Andreassen BU, Eldrup E, Dela F, Pedersen BK: Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mech Ageing Dev. 2003, 124: 495-502. 10.1016/S0047-6374(03)00027-7.View ArticlePubMed
  9. Ershler WB, Keller ET: Age-associated increased interleukin-6 gene expression, late life disease, and frailty. Ann Rev Med. 2000, 51: 245-270. 10.1146/annurev.med.51.1.245.View ArticlePubMed
  10. Bruunsgaard H, Pedersen M, Pedersen BK: Aging and proinflammatory cytokines. Curr Opin Hematol. 2001, 8: 131-136. 10.1097/00062752-200105000-00001.View ArticlePubMed
  11. Forsey RJ, Thompson JM, Ernerudth J, Hurst TL, Strindhall J, Johansson B, Nilsson B-O, Wikby A: Plasma cytokine profile in elderly humans. Mech Ageing Dev. 2003, 124: 487-493. 10.1016/S0047-6374(03)00025-3.View ArticlePubMed
  12. Agrawal A, Lourenço EV, Gupta S, La Cava A: Gender-based differences in leptinemia in healthy aging, non-obese individuals associate with increased marker of oxidative stress. Int J Clin Exp Med. 2008, 1 (4): 305-309.PubMed CentralPubMed
  13. Smirnoff P, Almiral-Seliger D, Schwartz B: Serum leptin levels in the elderly: relationship with gender and nutritional status. J Nutr Health Aging. 2001, 5: 29-32.PubMed
  14. Ruhl CE, Everhart JE, Ding J, Goodpaster BH, Kanaya AM, Simonsick EM, Tylavsky FA, Harris TB: Health, aging, and body composition study. Serum leptin concentrations and body adipose measures in older black and white adults. Amer J Clin Nutr. 2004, 80: 576-583.PubMed
  15. Zhong N, Wu XP, Xu ZR, Wang AH, Luo XH, Cao XZ, Xie H, Shan PF, Liao EY: Relationship of serum leptin with age, body weight, body mass index, and bone mineral density in healthy mainland Chinese women. Clin Chim Acta. 2005, 351: 161-168. 10.1016/j.cccn.2004.09.003.View ArticlePubMed
  16. Plackett TP, Boehmer ED, Faunce DE, Kovacs EJ: Aging and innate immune cells. J Leuoc Biol. 2004, 76: 291-299. 10.1189/jlb.1103592.View Article
  17. Plowden J, Renshaw-Hoelscher M, Engleman C, Katz J, Sambhara S: Innate immunity in aging: impact on macrophage function. Aging Cell. 2004, 3: 161-167. 10.1111/j.1474-9728.2004.00102.x.View ArticlePubMed
  18. Lloberas J, Celada A: Effect of aging on macrophage function. Exp Gerontol. 2002, 37: 1325-1331. 10.1016/S0531-5565(02)00125-0.View ArticlePubMed
  19. Chelvarajan RL, Collins SM, Van Willigen JM, Bondada S: The unresponsiveness of aged mice to polysaccharide antigens is a result of a defect in macrophage function. J Leukoc Biol. 2005, 77: 503-512.View ArticlePubMed
  20. Nyugen J, Agrawal S, Gollapudi S, Gupta S: Impaired functions of peripheral blood monocyte subpopulations in aged humans. J Clin Immunol. 2010, 30: 806-813. 10.1007/s10875-010-9448-8.PubMed CentralView ArticlePubMed
  21. Pistoia V: Production of cytokines by human B cells in health and disease. Immunol Today. 1997, 18: 343-350. 10.1016/S0167-5699(97)01080-3.View ArticlePubMed
  22. Tumanov AV, Kuprash DV, Mach JA, Nedospasov SA, Chervonsky AV: Lymphotoxin and TNF produced by B cells are dispensable for maintenance of the follicle-associated epithelium bur are required for development of follicles in the Peyer’s patches. J Immunol. 2004, 173: 86-91.View ArticlePubMed
  23. Harris DP, Hyanes L, Sayles PC, Duso DK, Eaton SM, Lepak NM, Johson LL, Swain SL, Lund FE: Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol. 2000, 1: 475-482. 10.1038/82717.View ArticlePubMed
  24. Agrawal S, Gupta S: LR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors. J Clin Immunol. 2011, 31: 89-98. 10.1007/s10875-010-9456-8. Epub 2010 Sep 7. Erratum in: J Clin Immunol. 2011PubMed CentralView ArticlePubMed
  25. Agrawal S, Gollapudi S, Su H, Gupta S: Leptin activates human B cells to secrete TNF-α, IL-6, and IL-10 via JAK2/STAT3 and p38MAPK/ERK1/2 signaling pathway. J Clin Immunol. 2011, 31: 472-478. 10.1007/s10875-010-9507-1.PubMed CentralView ArticlePubMed
  26. Agrawal A, Agrawal S, Cao JN, Su H, Osann K, Gupta S: Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J Immunol. 2007, 178: 6912-6922.View ArticlePubMed
  27. Lord GM, Matarese G, Howard JK, Bloom SR, Lechler RL: Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leuco Biol. 2002, 72: 330-338.
  28. Fantuzzi G, Faggioni R: Leptin in the regulation of immunity, inflammation and hematopoiesis. J Leukoc Biol. 2000, 68: 437-446.PubMed
  29. Procaccini C, Lourenco EV, Matarese G, Cava A: Leptin signaling: a key pathway in immune responses. Curr Signal Transduct Ther. 2009, 4: 22-30. 10.2174/157436209787048711.PubMed CentralView ArticlePubMed
  30. Shen J, Sakaida I, Uchida K, Terai S, Okita K: Leptin enhances TNF-alpha production via p38 and JNK MAPK in LPS-stimulated Kuffer cells. Life Sci. 2005, 77: 1502-1515. 10.1016/j.lfs.2005.04.004.View ArticlePubMed
  31. Fruhbeck G: Intracellular signaling pathways activated by leptin. Biochem J. 2006, 393: 7-20.PubMed CentralView ArticlePubMed
  32. Spencer NF, Daynes RA: IL-12 directly stimulates expression of IL-10 by CD5+ B cells and IL-6 by both CD5+ and CD5- B cells; possible involvement in age-associated cytokine dysregulation. Int Immunol. 1997, 9: 745-754. 10.1093/intimm/9.5.745.View ArticlePubMed
  33. Rosa V, Orocaccini C, Cai G, Pirozzi G, Fontana S, Zappacosta S, Cava A, Matarese G: A key role of leptin in the control of regulatory T cells proliferation. Immunity. 2007, 26: 241-255. 10.1016/j.immuni.2007.01.011.View ArticlePubMed
  34. Blair PA, Noreña LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, Mauri C: CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity. 2010, 32: 129-140. 10.1016/j.immuni.2009.11.009.View ArticlePubMed
  35. Villasenor-Bustamante A, Alvarado-De La Berrera C, Richaud-Patin Y, Martinez-Ayala H, Llorente L: Possible role of IL-10 in autoantibody production and in the fate of human cord blood CD5+ B cells. Scand J Immunol. 1999, 49: 629-632. 10.1046/j.1365-3083.1999.00545.x.View ArticlePubMed
  36. Spencer NF, Daynes RA: IL-12 directly stimulates expression of IL-10 by CD5+ B cells and IL-6 by both CD5+ and CD5- B cells; possible involvement in age-associated cytokine dysregulation. Internat Immunol. 1997, 9: 745-754. 10.1093/intimm/9.5.745.View Article
  37. Gary-Gouy H, Harriage J, Bismuth G, Platzer C, Schmitt C, Dalloul AH: Human CD5+ B cell survival through stimulation of autocrine IL-10 production. Blood. 2000, 100: 4537-4543.View Article
  38. Sun CM, Deriaud E, Leclerc C, Lo-Man R: Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. Immunity. 2005, 22: 467-477. 10.1016/j.immuni.2005.02.008.View ArticlePubMed
  39. Pers JO, Jamin C, Youinous P, Charreire J: Role of IL-10 in the distribution of B cell subsets in the mouse B-1 cell population. Eur Cytokine Netw. 2003, 14: 178-185.PubMed
  40. Buffa S, Pellicanò M, Bulati M, Martorana A, Goldeck D, Caruso C, Pawelec G, Colonna-Romano G: A novel B cell population revealed by a CD38/CD24 gating strategy: CD38(−)CD24 (−) B cells in centenarian offspring and elderly people. Age (Dordr). 2012, 10.1007/s11357-012-9488-5.
  41. Gao J, Tian J, Lv Y, Shi F, Kong F, Shi H, Zhao L: Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells. Cancer Sci. 2009, 100: 389-395. 10.1111/j.1349-7006.2008.01053.x.View ArticlePubMed
  42. Saxena NK, Sharma D, Ding X, Lin S, Marra F, Merlin D, Anania FA: Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res. 2007, 67: 2497-2507. 10.1158/0008-5472.CAN-06-3075.PubMed CentralView ArticlePubMed
  43. Sanchez-Margallet V, Martin-Romero C: Human leptin signaling in human peripheral blood mononuclear cells: activation of the JAK-STAT pathway. Cell Immunol. 2001, 211: 30-36. 10.1006/cimm.2001.1815.View Article

Copyright

© Gupta et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.